Pretraga

Rezultati

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial [2015]

Thatcher, Nick; Hirsch, Fred R; Luft, Alexander V; Szczesna, Aleksandra; Ciuleanu, Tudor E; Dediu, Mircea; Ramlau, Rodryg; Galiulin, Rinat K; Bálint, Beatrix; Losonczy, György;

Kazarnowicz, Andrzej; Park, Keunchil; Schumann, Christian; Reck, Martin; Depenbrock, Henrik; Nanda, Shivani; Kruljac-Letunic, Anamarija; Kurek, Raffael; Paz-Ares, Luis; Socinski, Mark A;

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Group [2017]

M. Miguel; F. Holmes; B. Ejlertsen; S. Delaloge; B. Moy; H. Iwata; G. von Minckwitz; S. Chia; J. Mansi; C. Barrios;

Tomašević, Zorica I. ; M. Gnant...et al.; ExteNET Study Group;

Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data [2013]

Mauguen, Audrey; Pignon, Jean-Pierre; Burdett, Sarah; Domerg, Caroline; Fisher, David; Paulus, Rebecca; Mandrekar, Samithra J; Belani, Chandra P; Shepherd, Frances A; Eisen, Tim;

Pang, Herbert; Collette, Laurence; Sause, William T; Dahlberg, Suzanne E; Crawford, Jeffrey; O'Brien, Mary; Schild, Steven E; Parmar, Mahesh; Tierney, Jayne F; Pechoux, Cécile Le; Michiels, Stefan;

Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial [2015]

Blay, Jean-Yves; Pápai, Zsuzsanna; Tolcher, Anthony W; Italiano, Antoine; Cupissol, Didier; López-Pousa, Antonio; Chawla, Sant P; Bompas, Emmanuelle; Babović, Nada ; Penel, Nicolas;

Isambert, Nicolas; Staddon, Arthur P; Saâda-Bouzid, Esma; Santoro, Armando; Franke, Fabio A; Cohen, Patrick; Le-Guennec, Solenn; Demetri, George D;

Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study [2023]

Leal, Ticiana A; ...; Andric, Zoran G ; ...; (broj, koautora 25)

Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. [2024]

Zahm, Shelia; Bonde, Jens Peter; Chiu, Weihsueh A; Hoppin, Jane; Kanno, Jun; Abdallah, Mohamed; Blystone, Chad R; Calkins, Miriam M; Dong, Guang-Hui; Dorman, David C;

Fry, Rebecca; Guo, Huan; Haug, Line S; Hofmann, Jonathan N; Iwasaki, Motoki; Machala, Miroslav; Mancini, Francesca R; Maria-Engler, Silvya S; Møller, Peter; Ng, Jack C; Pallardy, Marc; Post, Gloria B; Salihovic, Samira; Schlezinger, Jennifer; Soshilov, Anatoly; Steenland, Kyle; Steffensen, Inger-Lise; Tryndyak, Volodymyr; White, Alexandra; Woskie, Susan; Fletcher, Tony; Ahmadi, Ayat; Ahmadi, Nahid; Benbrahim-Tallaa, Lamia; Bijoux, Wendy; Chittiboyina, Shirisha; de Conti, Aline; Facchin, Caterina; Madia, Federica; Mattock, Heidi; Merdas, Mira; Pasqual, Elisa; Suonio, Eero; Viegas, Susana; Zupunski, Ljubica ; Wedekind, Roland; Schubauer-Berigan, Mary K;

Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial [2018]

von, Minckwitz Gunter; Colleoni, Marco A; Kolberg, Hans-Christian; Morales, Serafin; Santi, Patricia Xavier; Tomasevic, Zorica I ; Zhang, Nan; Hanes, Vladimir

Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network [2023]

Ludwig, Heinz; ...; Bila, Jelena S. ; ...; (broj koautora 29)

Active surveillance of cervical intraepithelial neoplasia grade 2: 2025 British Society of Colposcopy and Cervical Pathology and European Society of Gynaecologic Oncology consensus statement [2025]

Kyrgiou, Maria; Bowden, Sarah J; Ellis, Laura Burney; Hammer, Anne; Lyons, Deirdre; Freeman, Wang Theresa; Kechagias, Konstantinos S; Kalliala, Ilkka; Preti, Mario; Kesic, Vesna I;

Zapardiel, Ignacio; Cruickshank, Margaret; Gultekin, Murat; Martin, Hirsch Pierre;

2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 [2022]

Farge, Dominique; ...; Antić, Darko A. ; ...; International Initiative on Thrombosis and Cancer (ITAC) advisory panel; (broj koautora 19)